Mark Nathan Wolf

Mark Nathan Wolf

Active Director Director DIN 06536610
DIN 06536610 First appointment Jun 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2013
Shareholding value •••• Premium profile

About Mark Nathan Wolf

Data last updated:

Mark Nathan Wolf is a Director at Contract Pharmacal Corporation India Private Limited (since 2013). The company operates in Pharma. Contract Pharmacal Corporation India Private Limited reported revenue of ₹10.47 Cr (FY 2024).

DIN 06536610
Primary Designation Director
Industry Pharma
First Appointment 24 Jun 2013
Oldest Company Age 13 yrs
Largest company Contract Pharmacal Corporation India Private Limited · ₹10.47 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jun 20132013₹10.47 Cr (FY 2024)Active

Board colleagues of Mark Nathan Wolf

Directorship timeline

Open interactive timeline →
Contract Pharmacal Corporation India Private Limited
Premium access

Shareholding and investment profile for Mark Nathan Wolf

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mark Nathan Wolf

Mark Nathan Wolf currently holds 1 directorship: Contract Pharmacal Corporation India Private Limited (Director, since 24 Jun 2013, revenue ₹10.47 Cr (FY 2024)).

Mark Nathan Wolf was first appointed on 24 Jun 2013 as Director at Contract Pharmacal Corporation India Private Limited.

The current boards of Mark Nathan Wolf's companies include Ketan Babulal Dalki (Contract Pharmacal Corporation India Private Limited), Matthew David Wolf (Contract Pharmacal Corporation India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available